OLD Category: signatures

Interferon Signaling is Diminished with Age and is Associated with Immune Checkpoint Blockade Efficacy in Triple-Negative Breast Cancer

• Sceneay J et al.,

Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients

• Zhu GQ et al.,

Diffuse large B-cell lymphoma: the stuff of cell-of-origin and microenvironment

• Pileri SA et al.,

The tumor microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV positive Diffuse Large B Cell Lymphoma

• Keane C et al.,

“Beige” Cross Talk Between the Immune System and Metabolism

• Banfai K et al.,

C3- and CR3-dependent microglial clearance protects photoreceptors in retinitis pigmentosa

• Silverman SM et al.,

Adipose Tissue Mast Cells Promote Human Adipose Beiging in Response to Cold

• Finlin BS et al.,

The fatty acid oleate is required for innate immune activation and pathogen defense in Caenorhabditis elegans

• Anderson SM et al.,

Faecal micro-RNAs in inflammatory bowel diseases

• Verdier J et al.,

PD-1hi CD8+ resident memory T cells balance immunity and fibrotic sequelae

• Wang Z, Wang S, Goplen NP...Johnson AJ, Vassallo R, Sun J

Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles

• Reynolds JA et al.,

Safety, clinical activity and biomarker assessments of atezolizumab from a Phase I study in advanced/recurrent ovarian and uterine cancers

• Liu JF et al.,